Patterns of hormonal response to the GnRH agonist leuprolide in brothers of women with polycystic ovary syndrome: A pilot study

Human Reproduction

Volumn 19, Issue 12, 2004, Pages 2742-2747

  Sir Petermann, T ^a,c   Cartes, A ^a   Maliqueo, M ^a   Vantman, D ^a   Gutierrez C ^a   Toloza, H ^a   Echiburu B ^a   Recabarren, S E ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CONCEPCIÓN   (Chile)

^c UNIVERSITY OF CHILE   (Chile)

Author keywords

GnRH agonist; Male phenotype; Polycystic ovary syndrome

Indexed keywords

ANDROSTENEDIONE; CYTOCHROME P450C17; GLUCOSE; GONADORELIN AGONIST; GONADOTROPIN; HYDROXYPROGESTERONE; INSULIN; LEUPRORELIN; LIPID; SEX HORMONE; TESTOSTERONE;

ADULT; AGE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENETIC HETEROGENEITY; GLUCOSE BLOOD LEVEL; GONADOTROPIN BLOOD LEVEL; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; LIPID ANALYSIS; MALE; MENSTRUAL CYCLE; NORMAL VALUE; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PILOT STUDY; PROVOCATION TEST; REFERENCE VALUE; SIBLING; SINGLE DRUG DOSE; STATISTICAL SIGNIFICANCE; STEROID BLOOD LEVEL;

EID: 11144256287     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh512     Document Type: Article

References (37)

1. Adams J, Polson DW and Franks S (1986) Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J 293, 355-359.
2. Barnes RB, Rosenfield RL, Burstein S and Ehrmann D (1989) Pituitary-ovarian responses to nafarelin testing in the polycystic ovary syndrome. N Engl J Med 320,559-565.
3. Carey AH, Chan KL, Short F, White D, Williamson R and Franks S (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf) 38,653-658.
4. Cicognani A, Alessandroni R, Pasini A, Pirazzoli P, Cassio A, Barbieri E and Cacciari E (2002) Low birth weight for gestational age and subsequent male gonadal function. J Pediatr 141,376-379.
5. Cohen PN, Givens JR, Wiser WL, Wilroy RS, Summitt RL and Coleman SA (1975) Polycystic ovarian disease, maturation arrest of spermiogenesis, and Klinefelter's syndrome in siblings of a family with familial hirsutism. Fertil Steril 26,1228-1238.
6. Cooper H, Spellacy W, Prem K and Cohen W (1968) Hereditary factors in the Stein-Leventhal syndrome. Am J Obstet Gynecol 100,371-387.
7. Crosignani PG and Nicolosi AE (2001) Polycystic ovarian disease: heritability and heterogeneity. Hum Reprod Update 7,3-7.
8. Ehrmann DA, Rosenfield RL, Barnes RB, Brigell DF and Sheikh Z (1992) Detection of functional ovarian hyperandrogenism in women with androgen excess. N Engl J Med 327,157-162.
9. Ehrmann DA, Barnes RB and Rosenfield RL (1995) Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 16,322-353.
10. Ferriman D and Purdie AW (1979) The inheritance of polycystic ovarian disease and a possible relationship to premature balding. Clin Endocrinol (Oxf) 11,291-300.
11. Francois I, de Zegher F, Spiessens C, D'Hooghe T and Vanderschueren D (1997) Low birth weight and subsequent male subfertility. Pediatr Res 42, 899-901.
12. Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333,853-861.
13. Franks S, Gharani N, Waterworth D, Batty S, White D, Williamson R and McCarthy M (1997) The genetic basis of polycystic ovary syndrome. Hum Reprod 12,2641-2648.
14. Ghai K and Rosenfield RL (1994) Maturation of the normal pituitary-testicular axis, as assessed by gonadotropin-releasing hormone agonist challenge. J Clin Endocrinol Metab 78,1336-1340.
15. Govind A, Obhrai MS and Clayton RN (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. J Clin Endocrinol Metab 84,38-43.
16. Hamilton JB (1951) Patterned loss of hair in man: types and incidence. Ann NY Acad Sci 53,708-728.
17. Hull MG (1987) Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. Gynecol Endocrinol 1, 235-245.
18. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinye M, Carrascosa A and Vicens-Calvet E (1993) Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 76,1599-1603.
19. Ibañez L, Potau N, Zampolli M, Virdis R, Gussinye M, Carrascosa A, Saenger P and Vicens-Calvet E (1994) Use of leuprolide acetate response patterns in the early diagnosis of pubertal disorders: comparison with the gonadotropin-releasing hormone test. J Clin Endocrinol Metab 78,30-35.
20. Ibañez L, Hall JE, Potau N, Carrascosa A, Prat N and Taylor AE (1996) Ovarian 17-hydroxyprogesterone hyperresponsiveness to gonadotropin-releasing hormone (GnRH) agonist challenge in women with polycystic ovary syndrome is not mediated by luteinizing hormone hypersecretion: evidence from GnRH agonist and human chorionic gonadotropin stimulation testing. J Clin Endocrinol Metab 81,4103-4117.
21. Jahanfar S, Eden JA, Warren P, Seppala M and Nguyen TV (1995) A twin study of polycystic ovary syndrome. Fertil Steril 63,478-486.
22. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR and Azziz R (1998) Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 83,3078-3082.
23. Lander ES and Schork NJ (1994) Genetic dissection of complex traits. Science 265,2037-2048.
24. Legro RS, Spielman R, Urbanek M, Driscoll D, Strauss JF 3rd and Dunaif A (1998a) Phenotype and genotype in polycystic ovary syndrome. Recent. Prog Horm Res 53,217-256.
25. Legro RS, Driscoll D, Strauss JF 3rd, Fox J and Dunaif A (1998b) Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 95,14956-14960.
26. Lego RS, Kunselman RA, Demers L, Wang SC, Bentley-Lewis R and Dunaif A (2002) Elevated dehydroepiandrosterone sulfate levels as the reproductive phenotype in the brothers of women with polycystic ovary syndrome. J Clin Endocrinol Metab 87,2134-2138.
27. Lunde O, Magnus P, Sandvik L and Hoglo S (1989) Familial clustering in the polycystic ovarian syndrome. Gynecol Obstet Invest 28,23-30.
28. Matsuda M and DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22,1462-1470.
29. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28,412-419.
30. Nestler JE and Jakubowicz DJ (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. J Clin Endocrinol Metab 82, 4075-4079.
31. Rosenfield RL, Barnes RB, Cara JF and Lucky AW (1990) Dysregulation of cytochrome P450c 17 alpha as the cause of polycystic ovarian syndrome. Fertil Steril 53,785-791.
32. Rosenfield RL, Perovic N, Ehrmann DA and Barnes RB (1996) Acute hormonal responses to the gonadotropin releasing hormone agonist leuprolide: dose-response studies and comparison to nafarelin - a clinical research center study. J Clin Endocrinol Metab 81,3408-3411.
33. Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47.
34. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Perez-Bravo F and Recabarren SE (2002) Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 17,2573-2579.
35. Sir-Petermann T, Codner E, Maliqueo M, Hitschfeld C, Echiburú B and Cassorla F (2004) Low androgen concentrations during infancy in sons of women with polycystic ovary syndrome (PCOS) [Abstract P1-553]. Proc 86th Annual Meeting of The Endocrine Society, 293.
36. Yildiz BO, Yarali H, Oguz H and Bayraktar M (2003) Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome. J Clin Endocrinol Metab 88, 2031-2036.
37. Zawadzky JK and Dunaif A (1992) Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In Hershman JM (ed.) Current Issue in Endocrinology and Metabolism. Blackwell, Boston, pp. 377-384.